SCHEMBL5010585

SCHEMBL5010585

CN(C)CCN(Cc1ccccc1)S(=O)(=O)c1ccc(F)c(Cl)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 1/20 0.62
HTR2C P28335 1/20 0.62
SLC6A4 P31645 1/20 0.62
TP53 P04637 4/20 0.56
MAPT P10636 1/20 0.48
LMNA P02545 2/20 0.48
PKM P14618 1/20 0.48
CNR2 P34972 2/20 0.48
RXFP1 Q9HBX9 1/20 0.48
MEN1 O00255 1/20 0.46
POLB P06746 1/20 0.46
KMT2A Q03164 1/20 0.46
CNR1 P21554 1/20 0.46
PSEN1 P49768 1/20 0.46
PSEN2 P49810 1/20 0.46
SPPL2A Q8TCT8 1/20 0.46
APH1B Q8WW43 1/20 0.46
NCSTN Q92542 1/20 0.46
APH1A Q96BI3 1/20 0.46
PSENEN Q9NZ42 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5010583 0.80 HTR2A (0.81) HTR2AHTR2CSLC6A4TP53MAPT
SCHEMBL5011454 0.78 HTR2A (0.77) HTR2AHTR2CSLC6A4TP53CNR2
SCHEMBL3851675 0.77 TAS2R14 (0.51) MAPTLMNAMEN1KMT2APSEN1
SCHEMBL5011732 0.77 HTR2A (1.00) HTR2AHTR2CSLC6A4TP53MAPT
SCHEMBL5011430 0.76 HTR2A (0.70) HTR2AHTR2CSLC6A4TP53MAPT
SCHEMBL5009433 0.75 HTR2A (0.61) HTR2AHTR2CSLC6A4TP53MAPT
SCHEMBL533000 0.75 ACLY (0.68) HTR2AHTR2CSLC6A4TP53LMNA
SCHEMBL5010582 0.74 CNR2 (0.71) HTR2AHTR2CSLC6A4TP53CNR2
SCHEMBL5012972 0.74 HTR2A (0.53) HTR2AHTR2CSLC6A4TP53MAPT
SCHEMBL5010683 0.73 HTR2A (0.70) HTR2AHTR2CSLC6A4TP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008093919-A1 USE OF N-BENZYL-N-(2-DIMETHYLAMINO-ETHYL)BENZENESULFONAMIDE DERIVATIVES FOR TREATING CENTRAL NERVOUS SYSTEM DISORDERS DONGBU HITEK CO., LTD. (KR) 2008-08-07 WO claimed
WO-2008093919-A1 USE OF N-BENZYL-N-(2-DIMETHYLAMINO-ETHYL)BENZENESULFONAMIDE DERIVATIVES FOR TREATING CENTRAL NERVOUS SYSTEM DISORDERS DONGBU HITEK CO., LTD. (KR) 2008-08-07 WO disclosed